To test this hypothesis, we first knocked down 6PGD in CRC cells and found that the expression of ALKBH5, METTL3, METTL14, and FTO were not significantly changed in CRC cells with the knockdown of 6PGD (Fig. S5B). This evidence concerns the gene FTO and colorectal carcinoma.